UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 18, 2022
Healthcare Business Resources Inc. |
(Exact name of registrant as specified in its charter) |
Delaware | | 000-56214 | | 84-3639946 |
(State or other jurisdiction of Incorporation or Organization) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
718 Thompson Lane, Suite 108-273 Nashville, TN | | 37204 |
(Address of principal executive offices) | | (Zip Code) |
Registrant's telephone number, including area code: 615-856-5542
________________________________________________
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None
Title of each class | Trading Symbol(s) | Name of exchange on which registered |
| | |
Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Resignation of Kenneth D. Hawkins
On July 18, 2022, Kenneth D. Hawkins tendered his resignation as a director of Healthcare Business Resources Inc. (the “Company”) to the Company effective immediately. The departure of Mr. Hawkins from his position as a member of the Company’s Board of Directors was for personal reasons. A copy of Mr. Hawkins’ letter of resignation is attached as Exhibit 17.1 hereto.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | HEALTHCARE BUSINESS RESOURCES INC. | |
| | | | |
| Dated: July 22, 2022 | By: | /s/Stephen Epstein | |
| Name: | Stephen Epstein | |
| | Title: | Chief Executive Officer and Chief Financial Officer | |
| | | | |
